应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KLTO Klotho Neurosciences, Inc.
交易中 02-23 13:37:25 EST
0.3300
+0.0773
+30.59%
最高
0.3372
最低
0.2590
成交量
672.63万
今开
0.2599
昨收
0.2527
日振幅
30.95%
总市值
2,427万
流通市值
1,874万
总股本
7,354万
成交额
210.01万
换手率
11.85%
流通股本
5,678万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Klotho Neurosciences, Inc.盘中异动 快速拉升5.42%报0.228美元
市场透视 · 02-19
Klotho Neurosciences, Inc.盘中异动 快速拉升5.42%报0.228美元
Klotho Neurosciences Inc - 提交出售和转售最多3490万普通股的招股说明书
美股速递 · 2025-12-06
Klotho Neurosciences Inc - 提交出售和转售最多3490万普通股的招股说明书
Klotho Neurosciences, Inc.盘中异动 早盘大幅拉升5.40%
市场透视 · 2025-11-24
Klotho Neurosciences, Inc.盘中异动 早盘大幅拉升5.40%
Klotho Neurosciences, Inc.盘中异动 快速拉升5.15%
市场透视 · 2025-11-22
Klotho Neurosciences, Inc.盘中异动 快速拉升5.15%
Klotho Neurosciences Inc签署价值3亿美元的韩国制药公司授权及合作开发协议
美股速递 · 2025-09-30
Klotho Neurosciences Inc签署价值3亿美元的韩国制药公司授权及合作开发协议
Klotho Neurosciences签署意向书收购Turn Biotechnologies精选资产,以3亿美元全球制药合作为支撑
美股速递 · 2025-09-30
Klotho Neurosciences签署意向书收购Turn Biotechnologies精选资产,以3亿美元全球制药合作为支撑
加载更多
公司概况
公司名称:
Klotho Neurosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Klotho Neurosciences, Inc.于2021年3月16日在特拉华州注册成立。该公司专门开发获得专利的新型疾病改良技术,包括治疗神经退行性疾病和与年龄相关疾病的关键发展。ANEW正在开发尖端的蛋白质、基因和细胞疗法,以治疗与年龄相关的病理,如阿尔茨海默病和帕金森病、ALS和罕见的神经退行性疾病。其他资产包括多项平台技术的全球权利,其中包括一个已被证明可以调节饥饿、食物摄入和体重减轻的黑皮质素肽库,以及ANEW名为Nanoject的干纳米颗粒粉末注射系统,这是一种用于安全、无痛地自我注射胰岛素、GLP-1激动剂、生育药物和许多其他药物、疫苗和蛋白质分子的专利医疗设备。
发行价格:
--
{"stockData":{"symbol":"KLTO","market":"US","secType":"STK","nameCN":"Klotho Neurosciences, Inc.","latestPrice":0.33,"timestamp":1771871840570,"preClose":0.2527,"halted":0,"volume":6726291,"delay":0,"changeRate":0.3058963197467354,"floatShares":56781700,"shares":73536700,"eps":-0.304642,"marketStatus":"交易中","change":0.0773,"latestTime":"02-23 13:37:25 EST","open":0.2599,"high":0.3372,"low":0.259,"amount":2100146.13946995,"amplitude":0.309458,"askPrice":0.3349,"askSize":100,"bidPrice":0.3243,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.304642,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771880400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2527,"preHourTrading":{"tag":"盘前","latestPrice":0.26,"preClose":0.2527,"latestTime":"09:07 EST","volume":6525,"amount":1699.60896675,"timestamp":1771855638778,"change":0.0073,"changeRate":0.028888,"amplitude":0.064899},"postHourTrading":{"tag":"盘后","latestPrice":0.2554,"preClose":0.2527,"latestTime":"19:46 EST","volume":7289,"amount":1862.5048,"timestamp":1771634779392,"change":0.0027,"changeRate":0.010685,"amplitude":0.030471},"volumeRatio":13.307193},"requestUrl":"/m/hq/s/KLTO","defaultTab":"news","newsList":[{"id":"2612281891","title":"Klotho Neurosciences, Inc.盘中异动 快速拉升5.42%报0.228美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612281891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612281891?lang=zh_cn&edition=full","pubTime":"2026-02-19 01:50","pubTimestamp":1771437009,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日01时50分,Klotho Neurosciences, Inc.股票出现异动,股价大幅上涨5.42%。Klotho Neurosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Sensei Biotherapeutics, Inc.、Moolec Science Sa C/Wts 30/01/2028、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Moolec Science Sa、Sensei Biotherapeutics, Inc.、Quince Therapeutics, Inc.较为活跃,换手率分别为863.48%、781.19%、192.65%,振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Sensei Biotherapeutics, Inc.、Moolec Science Sa,振幅分别为160.33%、108.11%、106.99%。Klotho Neurosciences, Inc.公司简介:Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物:癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219015009a4b0f7cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219015009a4b0f7cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"1193996753","title":"Klotho Neurosciences Inc - 提交出售和转售最多3490万普通股的招股说明书","url":"https://stock-news.laohu8.com/highlight/detail?id=1193996753","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193996753?lang=zh_cn&edition=full","pubTime":"2025-12-06 06:20","pubTimestamp":1764973231,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences Inc - 提交出售和转售最多3490万普通股的招股说明书","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2586934445","title":"Klotho Neurosciences, Inc.盘中异动 早盘大幅拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586934445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586934445?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:42","pubTimestamp":1763995372,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时42分,Klotho Neurosciences, Inc.股票出现异动,股价快速上涨5.40%。Klotho Neurosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.51%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃,换手率分别为471.62%、354.11%、46.51%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Enlivex Therapeutics Ltd.、Bioatla, Inc.,振幅分别为38.86%、31.22%、16.60%。Klotho Neurosciences, Inc.公司简介:Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物:癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242242539517aa91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242242539517aa91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2585715911","title":"Klotho Neurosciences, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585715911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585715911?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:06","pubTimestamp":1763744799,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时06分,Klotho Neurosciences, Inc.股票出现波动,股价快速上涨5.15%。Klotho Neurosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Osr Holdings, Inc.、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd.较为活跃,换手率分别为441.05%、20.33%、20.27%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ,振幅分别为63.22%、49.71%、47.00%。Klotho Neurosciences, Inc.公司简介:Klotho Neurosciences Inc致力于开发治疗慢性疾病的基本药物:癌症、心血管疾病和神经退行性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122010639a70976a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122010639a70976a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"1123209174","title":"Klotho Neurosciences Inc签署价值3亿美元的韩国制药公司授权及合作开发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1123209174","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123209174?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:34","pubTimestamp":1759235649,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences Inc与韩国制药公司签署了价值3亿美元的对外授权和合作开发合作协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"1151730193","title":"Klotho Neurosciences签署意向书收购Turn Biotechnologies精选资产,以3亿美元全球制药合作为支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=1151730193","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151730193?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:33","pubTimestamp":1759235639,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences签署意向书收购Turn Biotechnologies精选资产,以3亿美元全球制药合作为支撑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.klothoneuro.com","stockEarnings":[{"period":"1week","weight":0.144},{"period":"1month","weight":-0.2342},{"period":"3month","weight":-0.4542},{"period":"6month","weight":-0.6625},{"period":"1year","weight":-0.3245},{"period":"ytd","weight":-0.1256}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Klotho Neurosciences, Inc.于2021年3月16日在特拉华州注册成立。该公司专门开发获得专利的新型疾病改良技术,包括治疗神经退行性疾病和与年龄相关疾病的关键发展。ANEW正在开发尖端的蛋白质、基因和细胞疗法,以治疗与年龄相关的病理,如阿尔茨海默病和帕金森病、ALS和罕见的神经退行性疾病。其他资产包括多项平台技术的全球权利,其中包括一个已被证明可以调节饥饿、食物摄入和体重减轻的黑皮质素肽库,以及ANEW名为Nanoject的干纳米颗粒粉末注射系统,这是一种用于安全、无痛地自我注射胰岛素、GLP-1激动剂、生育药物和许多其他药物、疫苗和蛋白质分子的专利医疗设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.06215},{"month":2,"riseRate":0.25,"avgChangeRate":-0.068819},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.043975},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.218192},{"month":5,"riseRate":0.5,"avgChangeRate":-0.006199},{"month":6,"riseRate":0.75,"avgChangeRate":1.150026},{"month":7,"riseRate":0.25,"avgChangeRate":-0.147403},{"month":8,"riseRate":0.25,"avgChangeRate":-0.147672},{"month":9,"riseRate":0.5,"avgChangeRate":-0.1464},{"month":10,"riseRate":0.5,"avgChangeRate":-0.038644},{"month":11,"riseRate":0.25,"avgChangeRate":-0.077658},{"month":12,"riseRate":0.5,"avgChangeRate":-0.032823}],"exchange":"NASDAQ","name":"Klotho Neurosciences, Inc.","nameEN":"Klotho Neurosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Klotho Neurosciences, Inc.(KLTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Klotho Neurosciences, Inc.(KLTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Klotho Neurosciences, Inc.,KLTO,Klotho Neurosciences, Inc.股票,Klotho Neurosciences, Inc.股票老虎,Klotho Neurosciences, Inc.股票老虎国际,Klotho Neurosciences, Inc.行情,Klotho Neurosciences, Inc.股票行情,Klotho Neurosciences, Inc.股价,Klotho Neurosciences, Inc.股市,Klotho Neurosciences, Inc.股票价格,Klotho Neurosciences, Inc.股票交易,Klotho Neurosciences, Inc.股票购买,Klotho Neurosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Klotho Neurosciences, Inc.(KLTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Klotho Neurosciences, Inc.(KLTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}